Clinical Trial Update: Safety and Gut Microbiota Analysis of an Oral Microbiotherapy in Patients With Amyotrophic Lateral Sclerosis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and gut microbiota effects of an oral microbiotherapy in patients with amyotrophic lateral sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Oral microbiotherapy

Snippet

Sponsor: MaaT Pharma | Conditions: Amyotrophic Lateral Sclerosis, ALS | Phase 1 | Status: COMPLETED